ATM heterozygosity and cancer risk.
Patrick
P
Concannon
D000818:Animals; D001260:Ataxia Telangiectasia / Q000150:complications / Q000235:genetics*; D064007:Ataxia Telangiectasia Mutated Proteins; D001943:Breast Neoplasms / Q000235:genetics*; D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D020022:Genetic Predisposition to Disease; D006579:Heterozygote; D006801:Humans; D008325:Mammary Neoplasms, Experimental / Q000235:genetics; D051379:Mice; D020125:Mutation, Missense; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*; D018570:Risk Assessment; D025521:Tumor Suppressor Proteins
D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D025521:Tumor Suppressor Proteins; C576324:ATM protein, human; D064007:Ataxia Telangiectasia Mutated Proteins; C576325:Atm protein, mouse; D017346:Protein Serine-Threonine Kinases